Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD) both result in a reduction in GFR but by different mechanisms. Nevertheless, there is growing evidence of a relationship between AKI and CKD such that incomplete recovery of AKI may result in CKD. The pathophysiology of progression from AKI to CKD in humans is not well described. Here, as part of a multiparametric MRI study, longitudinal relaxation time (T 1 ) mapping was performed to assess differences in renal structure and function between AKI and CKD. METHODS: 57 participants; 10 AKI patients, 26 CKD patients and 21 healthy volunteers (HV) were included in this study. AKI patients (inpatient AKI stage 2/3, no pre-existing CKD) underwent MRI scans at the time of AKI, 90 days and a year later. Patients with CKD stage 3/4 underwent MRI within 3 months of a routine biopsy; mean eGFR was 39613 ml/min/1.73 m 2 and urine protein:creatinine ratio 1206188mg/mmol. HVs were age matched, had normal renal function and no proteinuria. MRI scans were performed on a 3T Philips Ingenia scanner. MR measures of structure and function were taken, including T 1 mapping as a marker of fibrosis and/or inflammation. RESULTS: Table 1 demonstrates T 1 values within the cortex and medulla for HVs, AKI patients at time of injury and at 3 months post-AKI, and CKD patients. AKI patients at the time of injury had the highest T 1 values in both the renal cortex and medulla; at 3 months post-AKI both cortical and medullary T 1 values had declined but remained elevated comapred to HV levels. Interestingly, at 3 months post-AKI cortical T 1 declined to a value similar to that of CKD patients, whilst medullary T 1 remained significantly higher than in CKD patients T 1 There were differences between AKI and CKD patients in the correlation of T1 values and biochemistry and histology variables. In AKI patients, higher T 1 values in the medulla correlated with larger changes in serum creatinine between peak inpatient value to creatinine at the first AKI scan (r ¼ 0.71, p ¼ 0.05), and between first scan and second scan (r¼0.844, p¼0.02). This pattern of high medullary T 1 values was not seen in CKD, instead correlations with clinical variables were observed with T 1 measurements in the cortex: cortical T 1 correlated negatively with eGFR (r¼-0.6, p¼0.002) and positively with interstitial fibrosis score (r¼-0.52, p¼0.02). CONCLUSIONS: This comparative study demonstrates that longitudinal relaxation time (T 1 ) mapping is able to identify important pathophysiological processes in AKI and CKD, and can demonstrate clear differences in the pattern the of injury between the two. T 1 changes were more marked in the medulla of patients with AKI, with increased T 1 values suggesting oedema or inflammation at time of AKI. In contrast, cortical changes were more closely correlated with important clinical parameters in CKD. Results also suggest that MRI has the potential to inform the transition from AKI to CKD. Incomplete recovery in MRI measures was seen at 90days after AKI, at which time the pattern of abnormalities more closely resembled those of CKD patients. AKI e alerts are increasingly being embedded into clinical practice with the aim of early identification of AKI and to allow additional measures to be taken to prevent its progression. This will result in an increase in AKI being listed as a diagnosis on discharge summaries. We aim to document current practice prior to the implementation of e alerts in out large district general hospital. METHODS: Patients with "Acute Kidney Injury", "AKI", "Acute Renal Failure" and "ARF" in the text of their immediate discharge summary written between 01/01/17 and 30/06/17 were identified. The discharge summaries were reviewed against the standard set by the "Think Kidneys" UK Renal Registry NHS programme. This lists the minimum data content required for the General Practitioner regarding an AKI episode. Details recommended include: the AKI stage according to the KDIGO classification; medications stopped and restarted; whether the AKI has resolved at hospital discharge and hospital or community follow up. Only patients surviving to hospital discharge were included. RESULTS: 348 patients with AKI were identified. Of these, 44.8% were discharged by general medical specialities, 19% by nephrology and 9.5% by general surgery. 16.4% patients were identified as having developed AKI in hospital. Only 1.1% patients had AKI documented by KDIGO stage on the discharge summary. 14 patients (4.0%) required renal replacement therapy. 50.6% patients had medications stopped as a result of AKI with 47.2% of these patients having one or more medication restarted during their inpatient stay. Only 49.7% patients had documented stable creatinine measurements or resolution of AKI at hospital discharge with 39.7% patients having no outcome of the episode of AKI documented on the discharge summary. 31.9% (111 patients) had community review or phlebotomy requested on the discharge summary. CONCLUSIONS: Distribution of patients with AKI documented on hospital discharge summaries was in keeping with previous observations. Severity of AKI according to KDIGO stage is not reliably reported. Outcome of the episode of AKI is underreported and over 30% of discharge summaries requested additional community intervention following discharge. These data suggest that increased education of hospital doctors regarding information recommended on a discharge summary is required. E alerts are likely to increase identification of AKI and therefore development in partnership with the community is vital.
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INTRODUCTION AND AIMS:
After solid organ transplantation, acute kidney injury (AKI) is a frequent complication. Lung-, heart-and liver transplantation (tx) are accompanied by significant blood loss and red blood cell (RBC) transfusion. Although packed RBC transfusions can be life saving ageing could result in release of toxic degradatiobn products such as extracellular hemoglobin (hb), heme and iron resulting in acute organ dysfunction.This study compares systemic heme release after orthotopic heart tx and kidney tx in patients. METHODS: Patients undergoing heart tx (n¼10 htx) or kidney tx (n¼26 ktx) at the Hannover Medical School were included in a prospective clinical trial and blood was drawn before surgery, during surgery, at 6 and 24h, 3 and 7 days after surgery. The free heme quantification was done by peroxidase enzyme activity measurement and compared to clinical outcome parameters (s-creatinine, LDH). RESULTS: Within 30min after surgery the htx-patients developed systemic increase of free heme from baseline levels (9 fmol/nl) up to 3760 -17255 fmol/ml after surgery. LDH increased from 278 up to 834 -4539 U/L after surgery. The rate of AKI was 60% and more frequently in patients with complicated surgeries and large number of pRBC 
